Go to the list of all blogs
Anna G's Avatar
published in Blogs
May 24, 2023
Xtrackers Russell US Multifactor ETF (DEUS): Riding the Momentum Wave with Ascending Momentum Indicator

Xtrackers Russell US Multifactor ETF (DEUS): Riding the Momentum Wave with Ascending Momentum Indicator

At Tickeron, we believe in unleashing the power of artificial intelligence to enhance trading decisions, and our marketing team plays a pivotal role in sharing this vision with the world.

Step into the world of Xtrackers Russell US Multifactor ETF (DEUS) as we uncover an intriguing development in its momentum. On May 22, 2023, DEUS's Momentum indicator climbed above the crucial 0 level, signifying a potential uptrend in the stock's price. In this blog post, we delve into the significance of this momentum surge and unlock the valuable insights provided by A.I.dvisor, offering statistical evidence of a high probability of success based on historical backtesting.

Understanding the Momentum Indicator: Before we explore the implications of DEUS's momentum shift, let's take a moment to understand the concept of the Momentum indicator. This technical tool compares the current price of a stock to its price at a previous point in time, typically 14 days ago. It measures the strength and velocity of price movements, providing insights into the stock's momentum and potential direction.

DEUS Rides the Momentum Wave: The recent ascent of DEUS's Momentum indicator above the 0 level carries significant implications for investors. This upward movement suggests that the stock's price has the momentum to continue its upward trajectory. In fact, the current price surpasses the price logged 14 days ago, further reinforcing the positive momentum signal. Traders and investors may consider capitalizing on this trend by buying the stock or exploring call options.

Data-Driven Insights from A.I.dvisor: A.I.dvisor, utilizing its sophisticated algorithms, backtested historical data to shed light on the potential success of DEUS's momentum surge. Out of 75 similar cases identified by A.I.dvisor, an impressive 63 of them resulted in successful outcomes. This statistically significant success rate of 84% adds weight to the potential profitability of riding the momentum wave with DEUS.

Investing with Confidence: While the ascending Momentum indicator presents an enticing opportunity, it is crucial for investors to exercise caution and conduct thorough analysis. Other factors such as market conditions, sector performance, and individual risk tolerance should also be taken into consideration. Consulting with qualified financial advisors can provide valuable guidance in making well-informed investment decisions.

Xtrackers Russell US Multifactor ETF (DEUS) exhibits an exciting momentum surge as its Momentum indicator ascends above the 0 level. This development suggests the stock has the potential to experience an uptrend in its price. The data-backed insights from A.I.dvisor, indicating a success rate of 84% in similar cases, provide a compelling case for considering this momentum shift. However, prudent investors should conduct their own research and seek professional advice to align investment decisions with their individual financial goals and risk tolerance.

Related Ticker: DEUS

Momentum Indicator for DEUS turns positive, indicating new upward trend

DEUS saw its Momentum Indicator move above the 0 level on August 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DEUS advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 383 cases where DEUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DEUS moved out of overbought territory on August 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 76 cases where DEUS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DEUS turned negative on August 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DEUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DEUS broke above its upper Bollinger Band on July 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN), Broadcom Inc. (NASDAQ:AVGO), Meta Platforms (NASDAQ:META), Eli Lilly & Co (NYSE:LLY), Micron Technology (NASDAQ:MU).

Industry description

The investment seeks investment results that correspond generally to the performance, before fees and expenses, of the Russell 1000 Comprehensive Factor Index. The fund, using a "passive" or indexing investment approach, seeks investment results that correspond generally to the performance of the underlying index, which is designed to track the equity market performance of companies in the United States selected on the investment style criteria ("factors") of quality,value,momentum,low volatility and size. It will invest at least 80% of its total assets (but typically far more) in component securities of the underlying index. The fund is non-diversified.

Market Cap

The average market capitalization across the Xtrackers Russell US Multifactor ETF ETF is 86.96B. The market cap for tickers in the group ranges from 200.35M to 5.05T. NVDA holds the highest valuation in this group at 5.05T. The lowest valued company is ANGI at 200.35M.

High and low price notable news

The average weekly price growth across all stocks in the Xtrackers Russell US Multifactor ETF ETF was 24%. For the same ETF, the average monthly price growth was 92%, and the average quarterly price growth was 273%. ILMN experienced the highest price growth at 16%, while AAP experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Xtrackers Russell US Multifactor ETF ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was -19% and the average quarterly volume growth was 14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 51
Price Growth Rating: 46
SMR Rating: 54
Profit Risk Rating: 62
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
DEUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category MidCapBlend

Profile
Details
Category
Mid-Cap Blend
Address
DBX ETF TRUST345 PARK AVENUENew York
Phone
2122505883
Web
www.DWS.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.